EUVIMEDEUVIMED entdecken
Crossref

Outcomes after primary tumor resection of metastatic pancreatic neuroendocrine tumors: An analysis of the National Cancer Database

Sarah R Kaslow, Leena Hani, Steven M Cohen, Christopher L Wolfgang, Greg D Sacks, Russell S Berman, Ann Y Lee, Camilo Correa-Gallego

Journal of Surgical Oncology · 2023-08 · 128 (2) · 262-270

DOI: 10.1002/jso.27280 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Surgical Oncology, online erschienen am 12.04.2023. Verfasst von Sarah R Kaslow und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, New York University Grossman School of Medicine, New York, New York, USA. Hauptthemen laut MEDLINE: Neuroendocrine Tumors, Liver Neoplasms, Neoplasms, Second Primary, Pancreatic Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 33 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

There is no consensus regarding the role of primary tumor resection for patients with metastatic pancreatic neuroendocrine tumors (panNET). We assessed surgical treatment patterns and evaluated the survival impact of primary tumor resection in patients with metastatic panNET.

Methods

Patients with synchronous metastatic nonfunctional panNET in the National Cancer Database (2004−2016) were categorized based on whether they underwent primary tumor resection. We used logistic regressions to assess associations with primary tumor resection. We performed survival analyses with Kaplan−Meier survival functions, log‐rank test, and Cox proportional hazard regression within a propensity score matched cohort.

Results

In the overall cohort of 2613 patients, 68% ( n = 839) underwent primary tumor resection. The proportion of patients who underwent primary tumor resection decreased over time from 36% (2004) to 16% (2016, p < 0.001). After propensity score matching on age at diagnosis, median income quartile, tumor grade, size, liver metastasis, and hospital type, primary tumor resection was associated with longer median overall survival (OS) (65 vs. 24 months; p < 0.001) and was associated with lower hazard of mortality (HR: 0.39, p < 0.001).

Conclusion

Primary tumor resection was significantly associated with improved OS, suggesting that, if feasible, surgical resection can be considered for well‐selected patients with panNET and synchronous metastasis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neuroendocrine TumorsLiver NeoplasmsNeoplasms, Second PrimaryPancreatic NeoplasmsHumansRetrospective StudiesSurvival Analysis

Autor:innen und Institutionen

  • Department of Surgery, New York University Grossman School of Medicine, New York, New York, USA.
  • Department of Surgery, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

Zitieren

APA

Kaslow, S. R., Hani, L., Cohen, S. M., Wolfgang, C. L., Sacks, G. D., Berman, R. S., Lee, A. Y., & Correa-Gallego, C. (2023). Outcomes after primary tumor resection of metastatic pancreatic neuroendocrine tumors: An analysis of the National Cancer Database. Journal of Surgical Oncology, 128(2), 262-270. https://doi.org/10.1002/jso.27280

Vancouver

Kaslow SR, Hani L, Cohen SM, Wolfgang CL, Sacks GD, Berman RS, et al. Outcomes after primary tumor resection of metastatic pancreatic neuroendocrine tumors: An analysis of the National Cancer Database. Journal of Surgical Oncology. 2023;128(2):262-270. doi:10.1002/jso.27280

BibTeX
@article{Kaslow2023,
  author = {Kaslow, Sarah R and Hani, Leena and Cohen, Steven M and Wolfgang, Christopher L and Sacks, Greg D and Berman, Russell S and Lee, Ann Y and Correa-Gallego, Camilo},
  title = {Outcomes after primary tumor resection of metastatic pancreatic neuroendocrine tumors: An analysis of the National Cancer Database},
  journal = {Journal of Surgical Oncology},
  year = {2023},
  volume = {128},
  number = {2},
  pages = {262--270},
  doi = {10.1002/jso.27280}
}
Kostenlos starten →